Domestic generic drug leading stocks: Hengrui Medicine, East China Pharmaceutical, Huahai Pharmaceutical, Puli Pharmaceutical, Jingxin Pharmaceutical, Xinlitai.
1, Hengrui Medicine
Jiangsu Hengrui Medicine Co., Ltd. is approved by the People's Government of Jiangsu Province, by Lianyungang Hengrui Group Co., Ltd. and other five initiators in April 1997 *** with the establishment of joint-stock limited company, is the largest anti-tumor drug research and production base.
2, East China Pharmaceutical
Hangzhou East China Pharmaceutical Group Company formerly known as Zhejiang Pharmaceutical Factory, founded in 1952, later renamed Hangzhou Second Pharmaceutical Factory, Hangzhou East China Pharmaceutical Factory.
On December 16, 1992, Hangzhou Huadong Pharmaceutical Group Company was established on the basis of Hangzhou Huadong Pharmaceutical Factory, which has developed into a joint-stock enterprise--Huadong Pharmaceuticals Co., Ltd. and four Sino-foreign equity joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co.) and more than 10 other holding pharmaceutical enterprises.
3, Huahai Pharmaceutical
Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989, its predecessor is Linhai City flood bridge synthetic chemical plant, in January 2001, the whole change was set up for the establishment of Zhejiang Huahai Pharmaceutical Company Limited.
3, the company's shares were successfully listed on the Shanghai Stock Exchange. Stock abbreviation: Huahai Pharmaceuticals, stock code: 600521.
4, Puli Pharmaceutical
Hainan Puli Pharmaceuticals Co., Ltd. was founded in 1992, is specialized in the research and development of chemical pharmaceutical preparations, production and sales of high-tech enterprises, has been through the China's pharmaceutical enterprises internationalization of the preparations of the pilot enterprise certification. The company has two wholly-owned subsidiaries, Zhejiang Puli Pharmaceutical Co., Ltd. and Hangzhou Saili Pharmaceutical Research Institute.
5, Jingxin Pharmaceutical
Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974, has developed into a national key high-tech enterprises, China's top 100 pharmaceutical companies, in July 2004, successfully listed on the Shenzhen Stock Exchange.
6, Xinlitai
Shenzhen Xinlitai Pharmaceutical Co., Ltd. was approved by the Ministry of Commerce of the People's Republic of China (Ministry of Commerce on the consent of Shenzhen Xinlitai Pharmaceutical Co., Ltd. restructuring into a sino-foreign equity joint venture approved by the Ministry of Commerce (Business Capital Approval [2007] No. 1016), and the Ministry of Commerce issued by the People's Republic of China (Ministry of Commerce), the "approval certificate of Taiwan, Hong Kong, Macau, and Overseas Chinese Investment Enterprises", and in June 2007, it was listed in the Shenzhen Stock Exchange. (hereinafter referred to as "Shenzhen Xinlitai") was established as a foreign-invested joint stock limited company with a registered capital of RMB 85 million, and at the same time, it has obtained the business license of enterprise legal person with the registration number of 440301501124347.
Expanded informationPolicies and regulations
Reference: